Marino BL, de Souza LR, Sousa K, Ferreira JV, Padilha EC, da Silva CH, Taft CA, Hage-Melim LI (2020) Parkinson’s disease: a review from pathophysiology to treatment. Mini Rev Med Chem 20:754–767

Article  CAS  PubMed  Google Scholar 

Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909

Article  CAS  PubMed  Google Scholar 

Kim D-Y, Leem Y-H, Park J-S, Park J-E, Park J-M, Kang JL, Kim H-S (2023) RIPK1 regulates microglial activation in lipopolysaccharide-induced neuroinflammation and MPTP-induced Parkinson’s disease mouse models. Cells 12:417

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Zhang J, Zhang Y, Wang Z, Song Y, Wei S, He M, You S, Jia J, Cheng J (2019) TRAF2 protects against cerebral ischemia-induced brain injury by suppressing necroptosis. Cell Death Dis 10:328

Article  PubMed  PubMed Central  Google Scholar 

Zhang S, Su Y, Ying Z, Guo D, Pan C, Guo J, Zou Z, Wang L, Zhang Z, Jiang Z (2019) RIP1 kinase inhibitor halts the progression of an immune-induced demyelination disease at the stage of monocyte elevation. Proc Natl Acad Sci 116:5675–5680

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wallach D, Kang T-B, Dillon CP, Green DR (2016) Programmed necrosis in inflammation: toward identification of the effector molecules. Science 352:aaf2154

Article  PubMed  Google Scholar 

Zhang S, Tang M-b, Luo H-y, Shi C-h, Xu Y-m (2017) Necroptosis in neurodegenerative diseases: a potential therapeutic target. Cell Death Dis 8:e2905–e2905

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iannielli A, Bido S, Folladori L, Segnali A, Cancellieri C, Maresca A, Massimino L, Rubio A, Morabito G, Caporali L (2018) Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson’s disease models. Cell Rep 22:2066–2079

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu J-r, Wang J, Zhou S-k, Yang L, Yin J-l, Cao J-p, Cheng Y-b (2015) Necrostatin-1 protection of dopaminergic neurons. Neural Regen Res 10:1120–1124

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anh NH, Kim SJ, Long NP, Min JE, Yoon YC, Lee EG, Kim M, Kim TJ, Yang YY, Son EY (2020) Ginger on human health: a comprehensive systematic review of 109 randomized controlled trials. Nutrients 12:157

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karam A, Nadia A, Abd E, Nemat A, Siham M (2014) Protective effect of ginger (Zingiber officinale) on Alzheimer’s disease induced in rats. J Neuroinfect Dis 5:1–10

Google Scholar 

Li J-M, Zhao Y, Sun Y, Kong L-D (2020) Potential effect of herbal antidepressants on cognitive deficit: pharmacological activity and possible molecular mechanism. J Ethnopharmacol 257:112830

Article  CAS  PubMed  Google Scholar 

Ghayur MN, Gilani AH, Ahmed T, Khalid A, Nawaz SA, Agbedahunsi JM, Choudhary MI, Houghton PJ (2008) Muscarinic, Ca++ antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 60:1375–1383

Article  CAS  PubMed  Google Scholar 

Tanaka K, Arita M, Sakurai H, Ono N, Tezuka Y (2015) Analysis of chemical properties of edible and medicinal ginger by metabolomics approach. BioMed Res Int 2015:671058

Article  PubMed  PubMed Central  Google Scholar 

Zhang F, Zhang J-G, Yang W, Xu P, Xiao Y-L, Zhang H-T (2018) 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation. Biomed pharmacother 107:1523–1529

Article  CAS  PubMed  Google Scholar 

Abdallah HM, El-Halawany A, El-Sayed NS, Salah El-Dine R (2024) 6-Paradol modulates the amyloidogenic pathway and cognitive decline in a streptozotocin mouse model of sporadic alzheimer’s disease; in-vivo and insilico studies. Egypt J Chem 67:105–114

Google Scholar 

Sapkota A, Park SJ, Choi JW (2019) Neuroprotective effects of 6-shogaol and its metabolite, 6-paradol, in a mouse model of multiple sclerosis. Biomol Ther 27:152–159

Article  CAS  Google Scholar 

Gaire BP, Kwon OW, Park SH, Chun K-H, Kim SY, Shin DY, Choi JW (2015) Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia. PLoS ONE 10:e0120203

Article  PubMed  PubMed Central  Google Scholar 

Oñate M, Catenaccio A, Salvadores N, Saquel C, Martinez A, Moreno-Gonzalez I, Gamez N, Soto P, Soto C, Hetz C (2020) The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease. Cell Death Differ 27:1169–1185

Article  PubMed  Google Scholar 

Khidr HY, Hassan NF, Abdelrahman S, El-Ansary MR, El-Yamany MF, Rabie MA (2023) Formoterol attenuated mitochondrial dysfunction in rotenone-induced Parkinson’s disease in a rat model: role of PINK-1/PARKIN and PI3K/Akt/CREB/BDNF/TrKB axis. Int Immunopharmacol 125:111207

Article  CAS  PubMed  Google Scholar 

Mohamed YT, Salama A, Rabie MA, Abd El Fattah MA (2023) Neuroprotective effect of secukinumab against rotenone induced Parkinson’s disease in rat model: Involvement of IL-17, HMGB-1/TLR4 axis and BDNF/TrKB cascade. Int Immunopharmacol 114:109571

Article  CAS  PubMed  Google Scholar 

Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tashiro M, Okubo S, Shimotakahara S, Hatanaka H, Yasuda H, Kainosho M, Yokoyama S, Shindo H (2003) NMR structure of ubiquitin-like domain in PARKIN: gene product of familial Parkinson’s disease. J Biomol NMR 25:153–156

Article  CAS  PubMed  Google Scholar 

Radhakrishnan I, Pérez-Alvarado GC, Parker D, Dyson HJ, Montminy MR, Wright PE (1997) Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator: coactivator interactions. Cell 91:741–752

Article  CAS  PubMed  Google Scholar 

Schubert AF, Gladkova C, Pardon E, Wagstaff JL, Freund SM, Steyaert J, Maslen SL, Komander D (2017) Structure of PINK1 in complex with its substrate ubiquitin. Nature 552:51–56

Article  CAS  PubMed  PubMed Central  Google Scholar 

Traub S, Stahl H, Rosenbrock H, Simon E, Florin L, Hospach L, Hörer S, Heilker R (2017) Pharmaceutical characterization of tropomyosin receptor kinase B-agonistic antibodies on human induced pluripotent stem (hiPS) cell-derived neurons. J Pharmacol Exp Ther 361:355–365

Article  CAS  PubMed  Google Scholar 

Berman HM, Battistuz T, Bhat T, Bluhm W, Bourne P, Burkhardt K, Feng Z, Gilliland G, Iype L, Jain S (2002) The protein data bank. Acta Crystallogr D Biol Crystallogr 58:899–907

Article  PubMed  Google Scholar 

Zeleke D, Eswaramoorthy R, Belay Z, Melaku Y (2020) Synthesis and antibacterial, antioxidant, and molecular docking analysis of some novel quinoline derivatives. J Chem 2020:1–16

Article  Google Scholar 

El-Halawany AM, Hattori M (2012) Anti-oestrogenic diarylheptanoids from Aframomum melegueta with in silico oestrogen receptor alpha binding conformation similar to enterodiol and enterolactone. Food Chem 134:219–226

Article  CAS  Google Scholar 

Sayed AS, El Sayed NS, Budzyńska B, Skalicka-Woźniak K, Ahmed MK, Kandil EA (2022) Xanthotoxin modulates oxidative stress, inflammation, and MAPK signaling in a rotenone-induced Parkinson’s disease model. Life Sci 310:121129

Article  CAS  PubMed  Google Scholar 

Carvalho MM, Campos FL, Marques M, Soares-Cunha C, Kokras N, Dalla C, Leite-Almeida H, Sousa N, Salgado AJ (2017) Effect of levodopa on reward and impulsivity in a rat model of Parkinson’s disease. Front Behav Neurosci 11:145